Revitalist Lifestyle and Wellness Ltd.
Revitalist Lifestyle and Wellness Ltd. (RVLWF) Stock Competitors & Peer Comparison
See (RVLWF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RVLWF | $0.04 | +0.00% | 5.4M | -0.30 | -$0.13 | N/A |
| FSNUY | $11.91 | +2.58% | 107.3B | 14.89 | $0.80 | +2.40% |
| FSNUF | $54.35 | +0.00% | 30.6B | 17.04 | $3.19 | +2.08% |
| JDHIY | $6.85 | +0.00% | 22B | 27.40 | $0.25 | N/A |
| JDHIF | $5.85 | +0.00% | 18.8B | 23.40 | $0.25 | N/A |
| IHHHF | $1.71 | +0.00% | 15.1B | 28.50 | $0.06 | +1.50% |
| FMCQF | $43.08 | +0.00% | 12B | 11.25 | $3.83 | +3.79% |
| BDULF | $0.66 | +0.00% | 10.5B | 22.00 | $0.03 | +4.77% |
| BDUUF | $0.64 | -1.15% | 10.2B | 21.44 | $0.03 | +4.90% |
| BDUUY | $23.41 | +0.00% | 9.3B | 19.03 | $1.23 | +5.28% |
Stock Comparison
RVLWF vs FSNUY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, FSNUY has a market cap of 107.3B. Regarding current trading prices, RVLWF is priced at $0.04, while FSNUY trades at $11.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FSNUY's P/E ratio is 14.89. In terms of profitability, RVLWF's ROE is +3.95%, compared to FSNUY's ROE of +0.07%. Regarding short-term risk, RVLWF is less volatile compared to FSNUY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check FSNUY's competition here
RVLWF vs FSNUF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, FSNUF has a market cap of 30.6B. Regarding current trading prices, RVLWF is priced at $0.04, while FSNUF trades at $54.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FSNUF's P/E ratio is 17.04. In terms of profitability, RVLWF's ROE is +3.95%, compared to FSNUF's ROE of +0.07%. Regarding short-term risk, RVLWF is less volatile compared to FSNUF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check FSNUF's competition here
RVLWF vs JDHIY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, JDHIY has a market cap of 22B. Regarding current trading prices, RVLWF is priced at $0.04, while JDHIY trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JDHIY's P/E ratio is 27.40. In terms of profitability, RVLWF's ROE is +3.95%, compared to JDHIY's ROE of +0.09%. Regarding short-term risk, RVLWF is less volatile compared to JDHIY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check JDHIY's competition here
RVLWF vs JDHIF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, JDHIF has a market cap of 18.8B. Regarding current trading prices, RVLWF is priced at $0.04, while JDHIF trades at $5.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JDHIF's P/E ratio is 23.40. In terms of profitability, RVLWF's ROE is +3.95%, compared to JDHIF's ROE of +0.09%. Regarding short-term risk, RVLWF is less volatile compared to JDHIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check JDHIF's competition here
RVLWF vs IHHHF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, IHHHF has a market cap of 15.1B. Regarding current trading prices, RVLWF is priced at $0.04, while IHHHF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas IHHHF's P/E ratio is 28.50. In terms of profitability, RVLWF's ROE is +3.95%, compared to IHHHF's ROE of +0.07%. Regarding short-term risk, RVLWF and IHHHF have similar daily volatility (0.00).Check IHHHF's competition here
RVLWF vs FMCQF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, FMCQF has a market cap of 12B. Regarding current trading prices, RVLWF is priced at $0.04, while FMCQF trades at $43.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FMCQF's P/E ratio is 11.25. In terms of profitability, RVLWF's ROE is +3.95%, compared to FMCQF's ROE of +0.07%. Regarding short-term risk, RVLWF is less volatile compared to FMCQF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check FMCQF's competition here
RVLWF vs BDULF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BDULF has a market cap of 10.5B. Regarding current trading prices, RVLWF is priced at $0.04, while BDULF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BDULF's P/E ratio is 22.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to BDULF's ROE of +0.15%. Regarding short-term risk, RVLWF and BDULF have similar daily volatility (0.00).Check BDULF's competition here
RVLWF vs BDUUF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BDUUF has a market cap of 10.2B. Regarding current trading prices, RVLWF is priced at $0.04, while BDUUF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BDUUF's P/E ratio is 21.44. In terms of profitability, RVLWF's ROE is +3.95%, compared to BDUUF's ROE of +0.15%. Regarding short-term risk, RVLWF and BDUUF have similar daily volatility (0.00).Check BDUUF's competition here
RVLWF vs BDUUY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BDUUY has a market cap of 9.3B. Regarding current trading prices, RVLWF is priced at $0.04, while BDUUY trades at $23.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BDUUY's P/E ratio is 19.03. In terms of profitability, RVLWF's ROE is +3.95%, compared to BDUUY's ROE of +0.15%. Regarding short-term risk, RVLWF is less volatile compared to BDUUY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check BDUUY's competition here
RVLWF vs RMYHY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, RMYHY has a market cap of 6.4B. Regarding current trading prices, RVLWF is priced at $0.04, while RMYHY trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RMYHY's P/E ratio is 30.33. In terms of profitability, RVLWF's ROE is +3.95%, compared to RMYHY's ROE of +0.06%. Regarding short-term risk, RVLWF is less volatile compared to RMYHY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check RMYHY's competition here
RVLWF vs RMSYF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, RMSYF has a market cap of 5.7B. Regarding current trading prices, RVLWF is priced at $0.04, while RMSYF trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RMSYF's P/E ratio is 356.71. In terms of profitability, RVLWF's ROE is +3.95%, compared to RMSYF's ROE of +0.06%. Regarding short-term risk, RVLWF and RMSYF have similar daily volatility (0.00).Check RMSYF's competition here
RVLWF vs BUHPF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BUHPF has a market cap of 4.3B. Regarding current trading prices, RVLWF is priced at $0.04, while BUHPF trades at $5.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BUHPF's P/E ratio is 20.19. In terms of profitability, RVLWF's ROE is +3.95%, compared to BUHPF's ROE of +0.25%. Regarding short-term risk, RVLWF and BUHPF have similar daily volatility (0.00).Check BUHPF's competition here
RVLWF vs MCVEF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, MCVEF has a market cap of 4.1B. Regarding current trading prices, RVLWF is priced at $0.04, while MCVEF trades at $27.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MCVEF's P/E ratio is 52.40. In terms of profitability, RVLWF's ROE is +3.95%, compared to MCVEF's ROE of +0.15%. Regarding short-term risk, RVLWF is less volatile compared to MCVEF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check MCVEF's competition here
RVLWF vs ANHGY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, RVLWF is priced at $0.04, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, RVLWF's ROE is +3.95%, compared to ANHGY's ROE of N/A. Regarding short-term risk, RVLWF and ANHGY have similar daily volatility (0.00).Check ANHGY's competition here
RVLWF vs BUGDF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BUGDF has a market cap of 3.8B. Regarding current trading prices, RVLWF is priced at $0.04, while BUGDF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BUGDF's P/E ratio is 16.96. In terms of profitability, RVLWF's ROE is +3.95%, compared to BUGDF's ROE of +0.25%. Regarding short-term risk, RVLWF and BUGDF have similar daily volatility (0.00).Check BUGDF's competition here
RVLWF vs MCVEY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, MCVEY has a market cap of 2.5B. Regarding current trading prices, RVLWF is priced at $0.04, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MCVEY's P/E ratio is 40.37. In terms of profitability, RVLWF's ROE is +3.95%, compared to MCVEY's ROE of +0.16%. Regarding short-term risk, RVLWF is less volatile compared to MCVEY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check MCVEY's competition here
RVLWF vs ORPEF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, ORPEF has a market cap of 2.3B. Regarding current trading prices, RVLWF is priced at $0.04, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, RVLWF's ROE is +3.95%, compared to ORPEF's ROE of -0.20%. Regarding short-term risk, RVLWF is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check ORPEF's competition here
RVLWF vs EXETF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, EXETF has a market cap of 2.1B. Regarding current trading prices, RVLWF is priced at $0.04, while EXETF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas EXETF's P/E ratio is 27.47. In terms of profitability, RVLWF's ROE is +3.95%, compared to EXETF's ROE of +0.48%. Regarding short-term risk, RVLWF is less volatile compared to EXETF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check EXETF's competition here
RVLWF vs LWSCF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, LWSCF has a market cap of 1.7B. Regarding current trading prices, RVLWF is priced at $0.04, while LWSCF trades at $17.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas LWSCF's P/E ratio is 48.36. In terms of profitability, RVLWF's ROE is +3.95%, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, RVLWF is less volatile compared to LWSCF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check LWSCF's competition here
RVLWF vs RAFLF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, RAFLF has a market cap of 1.5B. Regarding current trading prices, RVLWF is priced at $0.04, while RAFLF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RAFLF's P/E ratio is 26.67. In terms of profitability, RVLWF's ROE is +3.95%, compared to RAFLF's ROE of +0.05%. Regarding short-term risk, RVLWF is less volatile compared to RAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check RAFLF's competition here
RVLWF vs RHCGF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, RHCGF has a market cap of 1.4B. Regarding current trading prices, RVLWF is priced at $0.04, while RHCGF trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RHCGF's P/E ratio is -5.04. In terms of profitability, RVLWF's ROE is +3.95%, compared to RHCGF's ROE of -0.14%. Regarding short-term risk, RVLWF is less volatile compared to RHCGF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check RHCGF's competition here
RVLWF vs LTGHF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, LTGHF has a market cap of 1.2B. Regarding current trading prices, RVLWF is priced at $0.04, while LTGHF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas LTGHF's P/E ratio is -13.58. In terms of profitability, RVLWF's ROE is +3.95%, compared to LTGHF's ROE of +8.48%. Regarding short-term risk, RVLWF and LTGHF have similar daily volatility (0.00).Check LTGHF's competition here
RVLWF vs TTALF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, TTALF has a market cap of 1.1B. Regarding current trading prices, RVLWF is priced at $0.04, while TTALF trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas TTALF's P/E ratio is 12.43. In terms of profitability, RVLWF's ROE is +3.95%, compared to TTALF's ROE of +0.14%. Regarding short-term risk, RVLWF is less volatile compared to TTALF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check TTALF's competition here
RVLWF vs LTGHY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, LTGHY has a market cap of 1.1B. Regarding current trading prices, RVLWF is priced at $0.04, while LTGHY trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas LTGHY's P/E ratio is -11.77. In terms of profitability, RVLWF's ROE is +3.95%, compared to LTGHY's ROE of +0.38%. Regarding short-term risk, RVLWF is less volatile compared to LTGHY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check LTGHY's competition here
RVLWF vs RKAGY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, RKAGY has a market cap of 1.1B. Regarding current trading prices, RVLWF is priced at $0.04, while RKAGY trades at $8.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RKAGY's P/E ratio is 24.73. In terms of profitability, RVLWF's ROE is +3.95%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, RVLWF and RKAGY have similar daily volatility (0.00).Check RKAGY's competition here
RVLWF vs RYHTY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, RYHTY has a market cap of 1.1B. Regarding current trading prices, RVLWF is priced at $0.04, while RYHTY trades at $6.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RYHTY's P/E ratio is -4.59. In terms of profitability, RVLWF's ROE is +3.95%, compared to RYHTY's ROE of -0.14%. Regarding short-term risk, RVLWF and RYHTY have similar daily volatility (0.00).Check RYHTY's competition here
RVLWF vs RHKJF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, RVLWF is priced at $0.04, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, RVLWF's ROE is +3.95%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, RVLWF and RHKJF have similar daily volatility (0.00).Check RHKJF's competition here
RVLWF vs NWKHY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, NWKHY has a market cap of 854.5M. Regarding current trading prices, RVLWF is priced at $0.04, while NWKHY trades at $7.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NWKHY's P/E ratio is 10.39. In terms of profitability, RVLWF's ROE is +3.95%, compared to NWKHY's ROE of +0.16%. Regarding short-term risk, RVLWF and NWKHY have similar daily volatility (0.00).Check NWKHY's competition here
RVLWF vs WHTCF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, WHTCF has a market cap of 816.1M. Regarding current trading prices, RVLWF is priced at $0.04, while WHTCF trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas WHTCF's P/E ratio is -159.74. In terms of profitability, RVLWF's ROE is +3.95%, compared to WHTCF's ROE of -0.01%. Regarding short-term risk, RVLWF is less volatile compared to WHTCF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check WHTCF's competition here
RVLWF vs JXFGF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, JXFGF has a market cap of 770.4M. Regarding current trading prices, RVLWF is priced at $0.04, while JXFGF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JXFGF's P/E ratio is -5.80. In terms of profitability, RVLWF's ROE is +3.95%, compared to JXFGF's ROE of -0.11%. Regarding short-term risk, RVLWF is less volatile compared to JXFGF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check JXFGF's competition here
RVLWF vs KDGTF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, RVLWF is priced at $0.04, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, RVLWF's ROE is +3.95%, compared to KDGTF's ROE of N/A. Regarding short-term risk, RVLWF and KDGTF have similar daily volatility (0.00).Check KDGTF's competition here
RVLWF vs WFHG Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, WFHG has a market cap of 476.9M. Regarding current trading prices, RVLWF is priced at $0.04, while WFHG trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas WFHG's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to WFHG's ROE of +0.00%. Regarding short-term risk, RVLWF and WFHG have similar daily volatility (0.00).Check WFHG's competition here
RVLWF vs ORRRY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, RVLWF is priced at $0.04, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, RVLWF's ROE is +3.95%, compared to ORRRY's ROE of +7.04%. Regarding short-term risk, RVLWF and ORRRY have similar daily volatility (0.00).Check ORRRY's competition here
RVLWF vs BTMDW Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, RVLWF is priced at $0.04, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, RVLWF's ROE is +3.95%, compared to BTMDW's ROE of -0.35%. Regarding short-term risk, RVLWF is less volatile compared to BTMDW. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check BTMDW's competition here
RVLWF vs MFCSF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, MFCSF has a market cap of 220.1M. Regarding current trading prices, RVLWF is priced at $0.04, while MFCSF trades at $12.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MFCSF's P/E ratio is 15.85. In terms of profitability, RVLWF's ROE is +3.95%, compared to MFCSF's ROE of +0.27%. Regarding short-term risk, RVLWF is less volatile compared to MFCSF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check MFCSF's competition here
RVLWF vs MKLNF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, MKLNF has a market cap of 214.8M. Regarding current trading prices, RVLWF is priced at $0.04, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, RVLWF's ROE is +3.95%, compared to MKLNF's ROE of +0.16%. Regarding short-term risk, RVLWF and MKLNF have similar daily volatility (0.00).Check MKLNF's competition here
RVLWF vs HWAIF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, HWAIF has a market cap of 209.1M. Regarding current trading prices, RVLWF is priced at $0.04, while HWAIF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas HWAIF's P/E ratio is -6.48. In terms of profitability, RVLWF's ROE is +3.95%, compared to HWAIF's ROE of -0.39%. Regarding short-term risk, RVLWF is less volatile compared to HWAIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check HWAIF's competition here
RVLWF vs CHHHF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, CHHHF has a market cap of 168M. Regarding current trading prices, RVLWF is priced at $0.04, while CHHHF trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas CHHHF's P/E ratio is 8.90. In terms of profitability, RVLWF's ROE is +3.95%, compared to CHHHF's ROE of +0.28%. Regarding short-term risk, RVLWF is less volatile compared to CHHHF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check CHHHF's competition here
RVLWF vs COLRF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, COLRF has a market cap of 123M. Regarding current trading prices, RVLWF is priced at $0.04, while COLRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas COLRF's P/E ratio is -8.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to COLRF's ROE of +0.00%. Regarding short-term risk, RVLWF is less volatile compared to COLRF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check COLRF's competition here
RVLWF vs VTIAF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, VTIAF has a market cap of 111.1M. Regarding current trading prices, RVLWF is priced at $0.04, while VTIAF trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas VTIAF's P/E ratio is -9.11. In terms of profitability, RVLWF's ROE is +3.95%, compared to VTIAF's ROE of -0.53%. Regarding short-term risk, RVLWF is less volatile compared to VTIAF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check VTIAF's competition here
RVLWF vs TOKIF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, TOKIF has a market cap of 101.4M. Regarding current trading prices, RVLWF is priced at $0.04, while TOKIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas TOKIF's P/E ratio is -0.57. In terms of profitability, RVLWF's ROE is +3.95%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, RVLWF is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check TOKIF's competition here
RVLWF vs MCIOF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, RVLWF is priced at $0.04, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, RVLWF's ROE is +3.95%, compared to MCIOF's ROE of N/A. Regarding short-term risk, RVLWF and MCIOF have similar daily volatility (0.00).Check MCIOF's competition here
RVLWF vs NAFS Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, NAFS has a market cap of 49.1M. Regarding current trading prices, RVLWF is priced at $0.04, while NAFS trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NAFS's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to NAFS's ROE of +0.31%. Regarding short-term risk, RVLWF and NAFS have similar daily volatility (0.00).Check NAFS's competition here
RVLWF vs ASSF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, RVLWF is priced at $0.04, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ASSF's P/E ratio is -33.33. In terms of profitability, RVLWF's ROE is +3.95%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, RVLWF and ASSF have similar daily volatility (0.00).Check ASSF's competition here
RVLWF vs NVLPF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, NVLPF has a market cap of 22.7M. Regarding current trading prices, RVLWF is priced at $0.04, while NVLPF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NVLPF's P/E ratio is 25.96. In terms of profitability, RVLWF's ROE is +3.95%, compared to NVLPF's ROE of -0.01%. Regarding short-term risk, RVLWF is less volatile compared to NVLPF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check NVLPF's competition here
RVLWF vs USNU Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, USNU has a market cap of 22.2M. Regarding current trading prices, RVLWF is priced at $0.04, while USNU trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas USNU's P/E ratio is -9.41. In terms of profitability, RVLWF's ROE is +3.95%, compared to USNU's ROE of -1.70%. Regarding short-term risk, RVLWF is less volatile compared to USNU. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check USNU's competition here
RVLWF vs HQDA Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, RVLWF is priced at $0.04, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas HQDA's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to HQDA's ROE of -0.06%. Regarding short-term risk, RVLWF and HQDA have similar daily volatility (0.00).Check HQDA's competition here
RVLWF vs EVGRF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, EVGRF has a market cap of 11.9M. Regarding current trading prices, RVLWF is priced at $0.04, while EVGRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas EVGRF's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to EVGRF's ROE of +0.22%. Regarding short-term risk, RVLWF is less volatile compared to EVGRF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check EVGRF's competition here
RVLWF vs NUMIF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, NUMIF has a market cap of 11.3M. Regarding current trading prices, RVLWF is priced at $0.04, while NUMIF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NUMIF's P/E ratio is -1.17. In terms of profitability, RVLWF's ROE is +3.95%, compared to NUMIF's ROE of +11.51%. Regarding short-term risk, RVLWF is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check NUMIF's competition here
RVLWF vs GBCS Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, GBCS has a market cap of 10.7M. Regarding current trading prices, RVLWF is priced at $0.04, while GBCS trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas GBCS's P/E ratio is -10.29. In terms of profitability, RVLWF's ROE is +3.95%, compared to GBCS's ROE of +0.17%. Regarding short-term risk, RVLWF and GBCS have similar daily volatility (0.00).Check GBCS's competition here
RVLWF vs FPCG Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, RVLWF is priced at $0.04, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FPCG's P/E ratio is 0.09. In terms of profitability, RVLWF's ROE is +3.95%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, RVLWF and FPCG have similar daily volatility (0.00).Check FPCG's competition here
RVLWF vs XCRT Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, XCRT has a market cap of 8.6M. Regarding current trading prices, RVLWF is priced at $0.04, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas XCRT's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to XCRT's ROE of +0.26%. Regarding short-term risk, RVLWF is less volatile compared to XCRT. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check XCRT's competition here
RVLWF vs HLYK Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, HLYK has a market cap of 6.7M. Regarding current trading prices, RVLWF is priced at $0.04, while HLYK trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas HLYK's P/E ratio is -2.24. In terms of profitability, RVLWF's ROE is +3.95%, compared to HLYK's ROE of +0.65%. Regarding short-term risk, RVLWF is less volatile compared to HLYK. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check HLYK's competition here
RVLWF vs MAHN Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, MAHN has a market cap of 6.1M. Regarding current trading prices, RVLWF is priced at $0.04, while MAHN trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MAHN's P/E ratio is 250.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to MAHN's ROE of N/A. Regarding short-term risk, RVLWF and MAHN have similar daily volatility (0.00).Check MAHN's competition here
RVLWF vs BICX Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BICX has a market cap of 5.7M. Regarding current trading prices, RVLWF is priced at $0.04, while BICX trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BICX's P/E ratio is -1.62. In terms of profitability, RVLWF's ROE is +3.95%, compared to BICX's ROE of +0.28%. Regarding short-term risk, RVLWF and BICX have similar daily volatility (0.00).Check BICX's competition here
RVLWF vs RHEP Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, RHEP has a market cap of 2.9M. Regarding current trading prices, RVLWF is priced at $0.04, while RHEP trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RHEP's P/E ratio is 1.17. In terms of profitability, RVLWF's ROE is +3.95%, compared to RHEP's ROE of -9.49%. Regarding short-term risk, RVLWF is less volatile compared to RHEP. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check RHEP's competition here
RVLWF vs EPWCF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, RVLWF is priced at $0.04, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas EPWCF's P/E ratio is -0.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, RVLWF is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check EPWCF's competition here
RVLWF vs VLXC Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, VLXC has a market cap of 2.5M. Regarding current trading prices, RVLWF is priced at $0.04, while VLXC trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas VLXC's P/E ratio is -2.52. In terms of profitability, RVLWF's ROE is +3.95%, compared to VLXC's ROE of +0.74%. Regarding short-term risk, RVLWF is less volatile compared to VLXC. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check VLXC's competition here
RVLWF vs NRPR Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, NRPR has a market cap of 2.1M. Regarding current trading prices, RVLWF is priced at $0.04, while NRPR trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NRPR's P/E ratio is -0.03. In terms of profitability, RVLWF's ROE is +3.95%, compared to NRPR's ROE of N/A. Regarding short-term risk, RVLWF and NRPR have similar daily volatility (0.00).Check NRPR's competition here
RVLWF vs KJFI Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, KJFI has a market cap of 2.1M. Regarding current trading prices, RVLWF is priced at $0.04, while KJFI trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas KJFI's P/E ratio is -0.06. In terms of profitability, RVLWF's ROE is +3.95%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, RVLWF is less volatile compared to KJFI. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check KJFI's competition here
RVLWF vs SMAS Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, RVLWF is priced at $0.04, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SMAS's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to SMAS's ROE of N/A. Regarding short-term risk, RVLWF is less volatile compared to SMAS. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check SMAS's competition here
RVLWF vs MDGP Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, MDGP has a market cap of 1.5M. Regarding current trading prices, RVLWF is priced at $0.04, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MDGP's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to MDGP's ROE of -2.19%. Regarding short-term risk, RVLWF and MDGP have similar daily volatility (0.00).Check MDGP's competition here
RVLWF vs DPAT Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, DPAT has a market cap of 1.3M. Regarding current trading prices, RVLWF is priced at $0.04, while DPAT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas DPAT's P/E ratio is -1.83. In terms of profitability, RVLWF's ROE is +3.95%, compared to DPAT's ROE of +0.59%. Regarding short-term risk, RVLWF and DPAT have similar daily volatility (0.00).Check DPAT's competition here
RVLWF vs NOVC Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, RVLWF is priced at $0.04, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NOVC's P/E ratio is -0.20. In terms of profitability, RVLWF's ROE is +3.95%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, RVLWF and NOVC have similar daily volatility (0.00).Check NOVC's competition here
RVLWF vs PHMB Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, RVLWF is priced at $0.04, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas PHMB's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to PHMB's ROE of N/A. Regarding short-term risk, RVLWF is less volatile compared to PHMB. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check PHMB's competition here
RVLWF vs GNOW Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, RVLWF is priced at $0.04, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas GNOW's P/E ratio is -0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to GNOW's ROE of -12.49%. Regarding short-term risk, RVLWF and GNOW have similar daily volatility (0.00).Check GNOW's competition here
RVLWF vs JRSS Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, JRSS has a market cap of 846K. Regarding current trading prices, RVLWF is priced at $0.04, while JRSS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JRSS's P/E ratio is -0.10. In terms of profitability, RVLWF's ROE is +3.95%, compared to JRSS's ROE of -0.07%. Regarding short-term risk, RVLWF and JRSS have similar daily volatility (0.00).Check JRSS's competition here
RVLWF vs JNHMF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, JNHMF has a market cap of 779.5K. Regarding current trading prices, RVLWF is priced at $0.04, while JNHMF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JNHMF's P/E ratio is -0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to JNHMF's ROE of -101.83%. Regarding short-term risk, RVLWF and JNHMF have similar daily volatility (0.00).Check JNHMF's competition here
RVLWF vs GRST Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, GRST has a market cap of 772.6K. Regarding current trading prices, RVLWF is priced at $0.04, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas GRST's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to GRST's ROE of +0.17%. Regarding short-term risk, RVLWF and GRST have similar daily volatility (0.00).Check GRST's competition here
RVLWF vs MSITF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, MSITF has a market cap of 480K. Regarding current trading prices, RVLWF is priced at $0.04, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MSITF's P/E ratio is -0.10. In terms of profitability, RVLWF's ROE is +3.95%, compared to MSITF's ROE of N/A. Regarding short-term risk, RVLWF is less volatile compared to MSITF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check MSITF's competition here
RVLWF vs ARPC Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, ARPC has a market cap of 336.6K. Regarding current trading prices, RVLWF is priced at $0.04, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ARPC's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to ARPC's ROE of +3.10%. Regarding short-term risk, RVLWF is less volatile compared to ARPC. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check ARPC's competition here
RVLWF vs BNYN Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BNYN has a market cap of 286K. Regarding current trading prices, RVLWF is priced at $0.04, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BNYN's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, RVLWF is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check BNYN's competition here
RVLWF vs NXGT Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, NXGT has a market cap of 236.7K. Regarding current trading prices, RVLWF is priced at $0.04, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NXGT's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to NXGT's ROE of +0.03%. Regarding short-term risk, RVLWF and NXGT have similar daily volatility (0.00).Check NXGT's competition here
RVLWF vs SETO Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, SETO has a market cap of 234.5K. Regarding current trading prices, RVLWF is priced at $0.04, while SETO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SETO's P/E ratio is -1.88. In terms of profitability, RVLWF's ROE is +3.95%, compared to SETO's ROE of -0.15%. Regarding short-term risk, RVLWF and SETO have similar daily volatility (0.00).Check SETO's competition here
RVLWF vs CLRD Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, CLRD has a market cap of 149.2K. Regarding current trading prices, RVLWF is priced at $0.04, while CLRD trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas CLRD's P/E ratio is -0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, RVLWF is less volatile compared to CLRD. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check CLRD's competition here
RVLWF vs FCHS Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, FCHS has a market cap of 141.7K. Regarding current trading prices, RVLWF is priced at $0.04, while FCHS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FCHS's P/E ratio is -0.02. In terms of profitability, RVLWF's ROE is +3.95%, compared to FCHS's ROE of +0.20%. Regarding short-term risk, RVLWF and FCHS have similar daily volatility (0.00).Check FCHS's competition here
RVLWF vs TPIA Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, RVLWF is priced at $0.04, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas TPIA's P/E ratio is -0.15. In terms of profitability, RVLWF's ROE is +3.95%, compared to TPIA's ROE of +0.56%. Regarding short-term risk, RVLWF is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check TPIA's competition here
RVLWF vs AMBD Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, AMBD has a market cap of 85.6K. Regarding current trading prices, RVLWF is priced at $0.04, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas AMBD's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to AMBD's ROE of +1.11%. Regarding short-term risk, RVLWF is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check AMBD's competition here
RVLWF vs NMHLY Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, RVLWF is priced at $0.04, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, RVLWF's ROE is +3.95%, compared to NMHLY's ROE of N/A. Regarding short-term risk, RVLWF and NMHLY have similar daily volatility (0.00).Check NMHLY's competition here
RVLWF vs MSGP Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, MSGP has a market cap of 31.1K. Regarding current trading prices, RVLWF is priced at $0.04, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MSGP's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, RVLWF is less volatile compared to MSGP. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check MSGP's competition here
RVLWF vs DRWN Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, DRWN has a market cap of 24K. Regarding current trading prices, RVLWF is priced at $0.04, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas DRWN's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, RVLWF is less volatile compared to DRWN. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check DRWN's competition here
RVLWF vs PRMD Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, PRMD has a market cap of 20.3K. Regarding current trading prices, RVLWF is priced at $0.04, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas PRMD's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, RVLWF is less volatile compared to PRMD. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check PRMD's competition here
RVLWF vs HSMD Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, HSMD has a market cap of 18.4K. Regarding current trading prices, RVLWF is priced at $0.04, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas HSMD's P/E ratio is -0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, RVLWF and HSMD have similar daily volatility (0.00).Check HSMD's competition here
RVLWF vs SCAL Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, RVLWF is priced at $0.04, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SCAL's P/E ratio is 0.04. In terms of profitability, RVLWF's ROE is +3.95%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, RVLWF and SCAL have similar daily volatility (0.00).Check SCAL's competition here
RVLWF vs GENN Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, GENN has a market cap of 12.1K. Regarding current trading prices, RVLWF is priced at $0.04, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas GENN's P/E ratio is -0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to GENN's ROE of +0.07%. Regarding short-term risk, RVLWF is less volatile compared to GENN. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check GENN's competition here
RVLWF vs CHCR Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, RVLWF is priced at $0.04, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas CHCR's P/E ratio is -0.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to CHCR's ROE of N/A. Regarding short-term risk, RVLWF and CHCR have similar daily volatility (0.00).Check CHCR's competition here
RVLWF vs ACGI Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, ACGI has a market cap of 10.5K. Regarding current trading prices, RVLWF is priced at $0.04, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ACGI's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, RVLWF is less volatile compared to ACGI. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check ACGI's competition here
RVLWF vs CEVE Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, CEVE has a market cap of 8.6K. Regarding current trading prices, RVLWF is priced at $0.04, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas CEVE's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to CEVE's ROE of +2.26%. Regarding short-term risk, RVLWF is less volatile compared to CEVE. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check CEVE's competition here
RVLWF vs WEQL Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, WEQL has a market cap of 7.2K. Regarding current trading prices, RVLWF is priced at $0.04, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas WEQL's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to WEQL's ROE of +0.21%. Regarding short-term risk, RVLWF is less volatile compared to WEQL. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check WEQL's competition here
RVLWF vs PAOG Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, PAOG has a market cap of 5K. Regarding current trading prices, RVLWF is priced at $0.04, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas PAOG's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to PAOG's ROE of +0.03%. Regarding short-term risk, RVLWF is less volatile compared to PAOG. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check PAOG's competition here
RVLWF vs SLHGF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, SLHGF has a market cap of 4K. Regarding current trading prices, RVLWF is priced at $0.04, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SLHGF's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to SLHGF's ROE of -0.42%. Regarding short-term risk, RVLWF is less volatile compared to SLHGF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check SLHGF's competition here
RVLWF vs SLHPF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, RVLWF is priced at $0.04, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SLHPF's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to SLHPF's ROE of -0.42%. Regarding short-term risk, RVLWF is less volatile compared to SLHPF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check SLHPF's competition here
RVLWF vs ERUC Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, RVLWF is priced at $0.04, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ERUC's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to ERUC's ROE of N/A. Regarding short-term risk, RVLWF and ERUC have similar daily volatility (0.00).Check ERUC's competition here
RVLWF vs BBAL Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, RVLWF is priced at $0.04, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BBAL's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to BBAL's ROE of +0.45%. Regarding short-term risk, RVLWF and BBAL have similar daily volatility (0.00).Check BBAL's competition here
RVLWF vs NMMCF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, RVLWF is priced at $0.04, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to NMMCF's ROE of +0.21%. Regarding short-term risk, RVLWF and NMMCF have similar daily volatility (0.00).Check NMMCF's competition here
RVLWF vs PPRG Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, RVLWF is priced at $0.04, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas PPRG's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to PPRG's ROE of -0.58%. Regarding short-term risk, RVLWF and PPRG have similar daily volatility (0.00).Check PPRG's competition here
RVLWF vs KONEF Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, KONEF has a market cap of 1.6K. Regarding current trading prices, RVLWF is priced at $0.04, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas KONEF's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to KONEF's ROE of -6.56%. Regarding short-term risk, RVLWF is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.Check KONEF's competition here
RVLWF vs OHAQ Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, RVLWF is priced at $0.04, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, RVLWF and OHAQ have similar daily volatility (0.00).Check OHAQ's competition here
RVLWF vs BNKL Comparison May 2026
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 5.4M. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, RVLWF is priced at $0.04, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BNKL's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to BNKL's ROE of -7.69%. Regarding short-term risk, RVLWF and BNKL have similar daily volatility (0.00).Check BNKL's competition here